Icon ICLR
NASDAQ ICLR
$169.68 -4.26 (-2.45%)
At close: Sep 17, 2026 · 4:00 PM EDT

Icon (ICLR) Other Accumulated Expenses (2009 - 2026)

Icon's (ICLR) quarterly Other Accumulated Expenses came in at $916.5 million in Q2 2026, up 1.96% year-over-year from $898.9 million in Q2 2025, and down 5.0% quarter-over-quarter from $964.8 million in Q1 2026.

Analysis

Icon (ICLR) Other Accumulated Expenses (2009 - 2026) Analysis & Trends

Icon (ICLR) has reported Other Accumulated Expenses for 18 consecutive years, with $916.5 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 1.96% year-over-year to $916.5 million in Q2 2026; TTM through Jun 2026 was $916.5 million, a 1.96% increase from a year earlier, with the FY2025 full-year figure at $904.8 million, down 0.54% from the prior year.
  • Other Accumulated Expenses was $916.5 million for Q2 2026 at Icon, down from $964.8 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $1.1 billion in Q3 2022 and troughed at $898.9 million in Q2 2025.
  • A 5-year average of $992.6 million and a median of $996.7 million in 2023 frame the typical range for Other Accumulated Expenses.
  • Across the five-year window, Other Accumulated Expenses surged 192.47% in 2022 and slipped 17.29% in 2023, its largest moves.
  • Over 5 years, Other Accumulated Expenses stood at $1.0 billion in 2022, then dropped by 9.64% to $908.2 million in 2023, then increased by 0.18% to $909.8 million in 2024, then retreated by 0.54% to $904.8 million in 2025, then grew by 1.29% to $916.5 million in 2026.
  • The last three Other Accumulated Expenses figures came in at $916.5 million (Q2 2026), $964.8 million (Q1 2026), and $904.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 916.52 Mn
Mar 31, 2026 964.79 Mn
Dec 31, 2025 904.83 Mn
Sep 30, 2025 998.47 Mn
Jun 30, 2025 898.91 Mn
Mar 31, 2025 994.31 Mn
Dec 31, 2024 909.78 Mn
Sep 30, 2024 1.05 Bn
Jun 30, 2024 999.07 Mn
Mar 31, 2024 1.00 Bn
Dec 31, 2023 908.15 Mn
Sep 30, 2023 948.83 Mn
Jun 30, 2023 994.88 Mn
Mar 31, 2023 1.03 Bn
Dec 31, 2022 1.01 Bn
Sep 30, 2022 1.15 Bn
Jun 30, 2022 1.12 Bn
Mar 31, 2022 1.08 Bn
Dec 31, 2021 949.63 Mn
Sep 30, 2021 794.88 Mn